Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

# Dr. Lewis R. Roberts

Home » # Dr. Lewis R. Roberts
The main mechanisms and strategies of HCC combination therapy

The main mechanisms and strategies of HCC combination therapy

Posted by By Xiaorong JI 2024.02.19
<Hepatology Digest>: What is the specific efficacy of combination therapies in improving tumor response in HCC, and how can the optimal treatment combinations and timing be determined?
Read More
The mechanism of tumor microenvironment affecting the occurrence and development of HCC

The mechanism of tumor microenvironment affecting the occurrence and development of HCC

Posted by By Xiaorong JI 2024.02.18
<Hepatology Digest>: How does the tumor immune microenvironment affect the efficacy of precision HCC therapy?
Read More
The main mechanisms and development prospects of HCC combination therapy

The main mechanisms and development prospects of HCC combination therapy

Posted by By Xiaorong JI 2024.01.31
Read More
Recent Posts
  • CASH 2026 | Prof. Wang Tianyou: Forty Years of Change in China’s Pediatric Disease Spectrum and Strategic Responses
  • Lymphoma In-Depth · ASH Special | Professor Qingqing Cai: New Advances in First-Line Treatment of Marginal Zone Lymphoma
  • ASH Global Perspectives | Prof. Wojciech Jurczak: First Results of BRUIN CLL-313 Suggest Non-Covalent BTK Inhibitors May Reshape First-Line CLL/SLL Treatment
  • ASH News Flash | Professor Huanling Zhu Highlights Breakthrough Leukemia Studies
  • ASH China Voices | Prof. Yongrong Lai & Prof. Lingling Shi: Validation of the “Guangxi Regimen” for Thalassemia Transplantation
Recent Comments
    Archives
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top